{
    "organizations": [],
    "uuid": "18bb546f0fb55513b89f8236e2083168a7ddd607",
    "author": "",
    "url": "https://www.reuters.com/article/brief-drreddys-labs-us-unit-announces-an/brief-dr-reddys-labs-u-s-unit-announces-anda-filing-for-migraine-candidate-idUSFWN1RE01T",
    "ord_in_thread": 0,
    "title": "BRIEF-Dr.Reddy's Labs' U.S. Unit Announces ANDA Filing For Migraine Candidate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2 (Reuters) - Dr.Reddyâ€™s Laboratories Ltd:\n* CO, U.S. UNIT PROMIUS PHARMA ANNOUNCE FILING OF AN NDA FOR MIGRAINE CANDIDATE\n* UPON APPROVAL, PRODUCT WILL BE COMMERCIALISED BY PROMIUS PHARMA Source text: bit.ly/2GOk7ib Further company coverage:\n ",
    "published": "2018-04-02T12:43:00.000+03:00",
    "crawled": "2018-04-02T13:00:10.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "laboratory",
        "ltd",
        "co",
        "unit",
        "promius",
        "pharma",
        "announce",
        "filing",
        "nda",
        "migraine",
        "candidate",
        "upon",
        "approval",
        "product",
        "commercialised",
        "promius",
        "pharma",
        "source",
        "text",
        "company",
        "coverage"
    ]
}